Matrix metalloproteinase proteolysis of the mycobacterial HSP65 protein as a potential source of immunogenic peptides in human tuberculosis

FEBS J. 2011 Sep;278(18):3277-86. doi: 10.1111/j.1742-4658.2011.08244.x. Epub 2011 Aug 8.

Abstract

Mycobacterium tuberculosis is the causative agent of human tuberculosis (TB). Mycobacterial secretory protein ESAT-6 induces matrix metalloproteinase (MMP)-9 in epithelial cells neighboring infected macrophages. MMP-9 then enhances recruitment of uninfected macrophages, which contribute to nascent granuloma maturation and bacterial growth. Disruption of MMP-9 function attenuates granuloma formation and bacterial growth. The abundant mycobacterial 65 kDa heat shock protein (HSP65) chaperone is the major target for the immune response and a critical component in M. tuberculosis adhesion to macrophages. We hypothesized that HSP65 is susceptible to MMP-9 proteolysis and that the resulting HSP65 immunogenic peptides affect host adaptive immunity. To identify MMPs that cleave HSP65, we used MMP-2 and MMP-9 gelatinases, the simple hemopexin domain MMP-8, membrane-associated MMP-14, MMP-15, MMP-16 and MMP-24, and glycosylphosphatidylinositol-linked MMP-17 and MMP-25. We determined both the relative cleavage efficiency of MMPs against the HSP65 substrate and the peptide sequence of the cleavage sites. Cleavage of the unstructured PAGHG474L C-terminal region initiates the degradation of HSP65 by MMPs. This initial cleavage destroys the substrate-binding capacity of the HSP65 chaperone. Multiple additional cleavages of the unfolded HSP65 then follow. MMP-2, MMP-8, MMP-14, MMP-15 and MMP-16, in addition to MMP-9, generate the known highly immunogenic N-terminal peptide of HSP65. Based on our biochemical data, we now suspect that MMP proteolysis of HSP65 in vivo, including MMP-9 proteolysis, also results in the abundant generation of the N-terminal immunogenic peptide and that this peptide, in addition to intact HSP65, contributes to the complex immunomodulatory interplay in the course of TB infection.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptive Immunity
  • Amino Acid Sequence
  • Antigens, Bacterial / chemistry
  • Antigens, Bacterial / metabolism*
  • Bacterial Proteins / chemistry
  • Bacterial Proteins / metabolism*
  • Catalytic Domain
  • Chaperonin 60 / chemistry
  • Chaperonin 60 / metabolism*
  • Epitopes / chemistry
  • Epitopes / metabolism
  • Humans
  • Hydrolysis / drug effects
  • Immunomodulation
  • Isoenzymes / antagonists & inhibitors
  • Isoenzymes / metabolism
  • Matrix Metalloproteinase 9 / genetics
  • Matrix Metalloproteinase 9 / metabolism
  • Matrix Metalloproteinase Inhibitors
  • Matrix Metalloproteinases / genetics
  • Matrix Metalloproteinases / metabolism*
  • Molecular Sequence Data
  • Mycobacterium tuberculosis / immunology*
  • Peptide Fragments / antagonists & inhibitors
  • Peptide Fragments / chemistry
  • Peptide Fragments / genetics
  • Peptide Fragments / metabolism*
  • Protease Inhibitors / pharmacology
  • Recombinant Proteins / antagonists & inhibitors
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / metabolism
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • Substrate Specificity
  • Tuberculosis / immunology*
  • Tuberculosis / prevention & control

Substances

  • Antigens, Bacterial
  • Bacterial Proteins
  • Chaperonin 60
  • Epitopes
  • Isoenzymes
  • Matrix Metalloproteinase Inhibitors
  • Peptide Fragments
  • Protease Inhibitors
  • Recombinant Proteins
  • heat-shock protein 65, Mycobacterium
  • Matrix Metalloproteinases
  • Matrix Metalloproteinase 9